[Successful individualized and targeted therapy of an NSCLC patient with Gefitinib based on a predictive assessment of the EGF-receptor mutation status].

Source:http://linkedlifedata.com/resource/pubmed/id/17455141

Download in:

View as

General Info

PMID
17455141